proscreen 6 panel multi-drug test card home drug test and drug abuse test screening product

 Quality Medical & Forensic
Diagnostics Since 1984 ...

...Wholesale Direct Prices on Home Health Diagnostic Test Kits... Alcohol and Drug of Abuse Screening, Pregnancy and Fertility Testing, General Health Diagnostics... Low Cost, Fast, Accurate and Confidential Diagnostic Health Solutions...


Drug Tests
Saliva Drug Tests
Drug Test FAQ
Alcohol Testing
Alcohol Breathalyzers
Drug/Alcohol Links
Pregnancy tests
Fertility tests




blood typing test kits




drug abuse test

HACKER SAFE certified sites prevent over 99.9% of hacker crime.

 

 

proscreen 6 panel multi-drug test card

ProScreen® 6 Panel Multi-Drug Test Card
Six parameter, All Inclusive Multiple Drug of Abuse Test (Dip Screen type)

order proscreen 6 panel home drug test and drug abuse test screening product

THC (MARIJUANA) • COCAINE  • OPIATESOXYCODONE  • BENZODIAZEPINES
•  METHAMPHETAMINE (inc. ECSTASY*)

A Rapid One-step Diagnostic Drug of Abuse Test to Screen for Six (6) targeted Illicit and Prescription Drugs and their Metabolites at the Minimum Cutoff Sensitivity Levels Established by the National Institute on Drug Abuse, World Health Organization (WHO) and SAMHSA. Approximately 90% of abused drugs are detectable using this one simple testing device.

INTENDED USE

SYMBOL

TARGET DRUG

CONC.

THC

MARIJUANA

50 ng/ml

COC

COCAINE

300 ng/ml

OPI

OPIATES

2000 ng/ml

OXY

OXYCODONE

100 ng/ml

MET

METHAMPHETAMINE

1000 ng/ml

BZO

BENZODIAZEPINES

200 ng/ml

The ProScreen® Multi-Drug 6 Panel Test is an forensic, all inclusive, point of use  screening test for the rapid detection of 11-nor- delta 9 -Tetrahydrocannabinol -9- carboxylic acid (THC/Marijuana), Cocaine and its metabolite, benzoylecgonine, Morphine and its related metabolites derived from opium (opiates), Oxycodone (Percodan, Percocet, Roxicodone, Oxycontin), Methamphetamines (including Ecstasy), and Benzodiazepines (Xanax, Valium etc.), in human urine at or above the system concentrations levels established as standard minimums by the National Institute on Drug Abuse (NIDA), the World Health Organization (WHO) and SAMHSA as shown in the chart to the right. Note system cut-off concentrations are expressed in nanograms per milliliter. For specific information concerning the individual drug or drug classifications covered in this test screen see the DRUG FAQ.
*While Methamphetamine tests will generally detect MDMA (Ecstasy), an MDMA specific test is recommended when screening specifically for MDMA or Ecstasy use.

SUMMARY AND EXPLANATION

For a comprehensive discussion on drug of abuse testing including typical detection time periods see the DRUG TESTING FAQ

Urine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of lateral flow based immunoassays identical to that employed in the ProScreen® Multi-Drug 6 Panel Screen Test have made them the most widely accepted method for screening urine for drugs of abuse. The ProScreen® 6 Multi-Drug Screening test is based on the principle of the highly specific immunochemical reactions of antigens and antibodies which are used for the analysis of specific compounds in human urine. The ProScreen® 6 Multi-Drug Screen is a rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of the six (6) targeted drugs and their metabolites listed above. For a description of these drugs of abuse along with other useful background information please refer to the DRUG FAQ page. The ProScreen® Multi-Drug Screen Panel Test is intended as an initial forensic screen for the presence of drug or drug metabolites at the time the test is performed. Because the test requires visual interpretation, it is recommended that a person other than the test subject interpret test results.

TEST PROCEDURE

•  Read the enclosed instruction manual completely.
•  Do not open the sealed test pouch until just prior to sample testing.
•  Collect a fresh urine sample in a clean container preferably glass.
Check the expiration date and remove the test device from the sealed pouch. Do not use the test past its expiration date. Remove the test cap exposing the 6 absorbent wicks. Do not touch the wicks or otherwise contaminate them.
• 
Dip the wicks only into the urine sample for approximately 20-30 seconds or until visible sample migration up the wicks and across the tests panels is observed
• 
Dip only the wicks. Do not allow the sample to come in contact with any other part of the test device or its plastic housing.
•  Read result within 3 to 8 minutes after the addition of samples. Do not read result after 8 minutes. If the drug test is left standing for longer than 8 minutes, the intensity of the colored lines may change or for technical reasons, a faint line may appear that should not be interpreted.
• 
Photocopy the developed test card for a permanent record of test results.

INTERPRETATION OF TEST RESULTS

Negative: Colored lines adjacent to each target drug name and in the control (C) regions will appear. The color intensity of the line for the target drug may be weaker or stronger than that of the control line however any line, no matter how faint should be interpreted as a negative result. Do not attempt to correlate the intensity or color of the test lines between the targeted drug panels. Also because development times vary for each target drug, results should not fully interpreted until 6-8 minutes have elapsed. Some drug panels, however, will develop test lines within 3 minutes or less producing negative results. A very faint line on the test region may indicate that the target drug in the sample is near the cutoff level for the test. While these results should be considered negative, confirmation of the sample by more analytical testing methods may be desired.
Positive:
Colored lines appear in the control regions (C) but do not develop in the test region. The absence of any line in any target drug test region indicates a positive result for that drug or drug metabolite. The example shown is a positive test for OXY (oxycodone) and MET (methamphetamine #1) and negative test for all other drugs. Note that test lines are not of equal intensity or color. Because of the various sensitivity cutoff level for each specific drug this result is normal. Also note that the first strip tests for two drugs on the same strip and shows two test areas #1 and #2. #1 test area corresponds to 1 MET and #2 test area corresponds to 2 OPI.
Invalid:
No line appears in the control region. Under no circumstances should a positive sample be identified until the control line (C) forms in the control test area. If the control line (C) does not form, the test result is inconclusive and the assay should be repeated with a new test device.
Note: The ProScreen® Multi-Drug 6 panel test is used to obtain visual qualitative result and is not intended as a quantitative assay.. This assay provides only a preliminary analytical test result as to the presence of the target drug and drug metabolites at the established minimum standards above. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography! mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. If confirmation of positive scans is required, we suggest the QuickScreen Pro At Home kit with Laboratory Confirmation of positive results.

AVAILABILITY AND ORDERING

The ProScreen® Multi-Drug 6 Panel Test Card screens for approximately 80% of the abused illicit or prescription drugs used today in one simple to use all inclusive device. Test cassettes are individually and hermetically sealed in a foil package clearly stamped with lot number and expiration date. A comprehensive instruction and product insert sheet is included covering greater detail on test procedure, clinical accuracy and cross-reactivity charts. The ProScreen® Multi-Drug 6 Panel test is available in packs of 1, 3, 6, 12, 24 and 100 tests. For bulk quantities of 250 or more please contact Customer Service.

Description Packaging Quantity Cost  

ProScreen® 6 Panel Multi-Drug Test

Each/Sealed

1 Test Pack

$15.90

order proscreen 6 panel drug abuse test
   

3 Test Pack

$42.00

order proscreen 6 panel drug abuse test
   

6 Test Pack

$72.00

order proscreen 6 panel drug abuse test
   

12 Test Pack

$132.00

order proscreen 6 panel drug abuse test
   

24 Test Pack

$222.00

order proscreen 6 panel drug abuse test
   

100 Test Pack

$775.00

order proscreen 6 panel drug abuse test

*If the order buttons are absent or inoperable, please use the pricing overview page to order.

Urine Sample Validity
and Adulteration Test Strips are available:
Adulteration Test
 

Professional specimen collection containers available separately: Specimen Containers

 

BorderHorztshdowlfta.gif (1664 bytes)

HACKER SAFE certified sites prevent over 99.9% of hacker crime.

Copyright ©1997-2012
all rights reserved